Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Infection in the Elderly”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchStudy completedNCT07025876
What this trial is testing

PhaseⅠClinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine

Who this might be right for
Streptococcus Pneumoniae Pneumonia
Jiangsu Province Centers for Disease Control and Prevention 240
Large-scale testing (Phase 3)Study completedNCT00560950
What this trial is testing

Revaccination With PNEUMOVAX(TM) 23 in Older Adults (V110-007)

Who this might be right for
Pneumococcal Infection
Merck Sharp & Dohme LLC 143
Large-scale testing (Phase 3)Study completedNCT03932682
What this trial is testing

Efficacy Study With QIVc in Pediatric Subjects

Who this might be right for
Influenza, Human
Seqirus 5,723
Large-scale testing (Phase 3)Study completedNCT05559476
What this trial is testing

A Study on the Immune Response and Safety Elicited by a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Influenza in Adults Aged 65 Years and Above

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 1,029
Not applicableUnknownNCT05126550
What this trial is testing

The Immunogenicity, Safety, and Effectiveness of the COVID-19 Inactivated Vaccine

Who this might be right for
COVID-19
PT. Kimia Farma (Persero) Tbk 435
Early research (Phase 1)Study completedNCT05126979
What this trial is testing

The Objectives of This Study Are Study of the Reactogenicity, Safety and Immunogenicity of Flu-M Inactivated Split Influenza Vaccine in Volunteers Aged 18-60 Years

Who this might be right for
Influenza
St. Petersburg Research Institute of Vaccines and Sera 45
Testing effectiveness (Phase 2)Study completedNCT00230750
What this trial is testing

Inactivated Influenza A/H5N1 Vaccine in the Elderly

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 261
Early research (Phase 1)Study completedNCT00678106
What this trial is testing

Study Of Dalbavancin Drug Levels Achieved In Hospitalized Adolescents Who Are Receiving Antibiotic Therapy For Bacterial Infections

Who this might be right for
Bacterial Infections
Pfizer 10
Large-scale testing (Phase 3)WithdrawnNCT05534048
What this trial is testing

Booster Study of PTX-COVID19-B in Adults Aged 18 Years and Older

Who this might be right for
SARS-CoV-2 Infection
Everest Medicines (Singapore) Pte. Ltd.
Large-scale testing (Phase 3)Study completedNCT06314724
What this trial is testing

Immunogenicity and Safety of Varicella Vaccine, Live in Healthy Children Aged 12~15 Months in the Philippines

Who this might be right for
Varicella
Sinovac (Dalian) Vaccine Technology Co., Ltd. 642
Large-scale testing (Phase 3)Study completedNCT06131554
What this trial is testing

A Clinical Trial to Evaluate the Immunogenicity and Safety of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) in Adults Aged 18 to 55 Years

Who this might be right for
Meningococcal Meningitis
CanSino Biologics Inc. 1,480
Not applicableNot Yet RecruitingNCT07644962
What this trial is testing

Research Project on the Interaction Between Immune Function and Infectious Diseases in Older Adults and the Development of Prevention and Control Strategies

Who this might be right for
Infectious DiseasesImmunosenescenceAging
Huashan Hospital 23,000
Testing effectiveness (Phase 2)Study completedNCT01419925
What this trial is testing

Assess the Safety and Immunogenicity of M-001 Influenza Vaccine as a Primer to TIV in Elderly Volunteers

Who this might be right for
InfluenzaHealthy
BiondVax Pharmaceuticals ltd. 120
Not applicableUnknownNCT05125874
What this trial is testing

Clinical Study for Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Booster Immunization

Who this might be right for
COVID-19 Pandemic
Livzon Pharmaceutical Group Inc. 45
Large-scale testing (Phase 3)Study completedNCT00161746
What this trial is testing

Safety and Immunogenicity Study of 3 Vaccinations With TICOVAC in 2 Dosages in Healthy Children Aged Between 6 Months and 3 Years

Who this might be right for
Encephalitis, Tick-borne
Pfizer
Testing effectiveness (Phase 2)Study completedNCT00374842
What this trial is testing

Study to Evaluate the Immunogenicity and Safety of 2 Formulations of GlaxoSmithKline (GSK) Biologicals' GSK1247446A Low Dose Influenza Vaccine Candidate

Who this might be right for
Influenza
GlaxoSmithKline 300
Not applicableUnknownNCT03004170
What this trial is testing

Telephone Counseling to Enhance the Quality and Safety of Romantic and Sexual Relationships in People Living and Aging With HIV

Who this might be right for
HIV Seropositivity
Oregon Health and Science University 343
Early research (Phase 1)Study completedNCT00214461
What this trial is testing

Safety, Tolerability, and Immunogenicity of a Clostridium Difficile Toxoid Vaccine in Healthy Elderly Volunteers

Who this might be right for
Clostridium Infections
Sanofi 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT06686654
What this trial is testing

Study of a Human Metapneumovirus/Respiratory Syncytial Virus mRNA Vaccine Candidate Encapsulated in a Lipid Nanoparticle-based Formulation in Adults Aged 60 Years and Older

Who this might be right for
Human Metapneumovirus ImmunizationRespiratory Syncytial Virus Immunization
Sanofi Pasteur, a Sanofi Company 1,530
Large-scale testing (Phase 3)Study completedNCT03909074
What this trial is testing

Clinical Trial of Enterovirus 71（EV71） Inactivated Vaccine in Children Aged 36-71 Months

Who this might be right for
Hand, Foot and Mouth Disease
Sinovac Biotech Co., Ltd 900
Next Page